QULIPTA ORAL FOR MIGRAINE PREVENTION

Qulipta is a leading migraine prevention oral option designed to help prevent migraine in patients who experience 4+ Monthly Migraine Days (MMDs). To support brand initiatives and conversations between healthcare providers and patients in this space, it’s essential to create impactful, cohesive visual brand assets that are clear, consistent, and medically appropriate—helping reinforce the brand story, strengthen recognition, and make key messages more engaging for healthcare providers as they present treatment options to their patients.

Below are creative assets produced that both aligned to the Qulipta brand and provided robust data in support of this treatment option.